Holen Sie sich die Stockscreener-App
29.35
2.85%
-0.86
Schlusskurs vom Vortag:
$30.21
Offen:
$31.18
24-Stunden-Volumen:
359.27K
Relative Volume:
1.04
Marktkapitalisierung:
$485.38M
Einnahmen:
$3.25M
Nettoeinkommen (Verlust:
$-116.80M
KGV:
-9.623
EPS:
-3.05
Netto-Cashflow:
$-98.17M
1W Leistung:
-2.49%
1M Leistung:
-2.62%
6M Leistung:
+279.47%
1J Leistung:
+64.52%
1-Tages-Spanne:
$28.99
$31.64
1-Wochen-Bereich:
$28.99
$31.64
52-Wochen-Spanne:
$5.6652
$42.39
Rapt Therapeutics Inc Stock (RAPT) Company Profile
Firmenname
Rapt Therapeutics Inc
Sektor
Branche
Telefon
(650) 489-9000
Adresse
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Vergleichen Sie RAPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
29.35 | 751.36M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Eingeleitet | Guggenheim | Buy |
| 2025-10-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-09-26 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-07-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2025-05-22 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-26 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-11-13 | Herabstufung | Stifel | Buy → Hold |
| 2024-11-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-11-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-14 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-05-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-22 | Herabstufung | UBS | Buy → Neutral |
| 2024-02-21 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-02-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-21 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-02-20 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-02-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-09-14 | Eingeleitet | Berenberg | Buy |
| 2023-08-09 | Eingeleitet | Stifel | Buy |
| 2023-06-15 | Eingeleitet | Barclays | Overweight |
| 2023-01-04 | Eingeleitet | Guggenheim | Buy |
| 2022-12-01 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-12-09 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-12 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-21 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-04-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-11-25 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-11-25 | Eingeleitet | UBS | Buy |
| 2019-11-25 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Rapt Therapeutics Inc Aktie (RAPT) Neueste Nachrichten
Can RAPT Therapeutics Inc. (0RA) stock attract ESG investments2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Can RAPT Therapeutics Inc. (0RA) stock resist broad market declinesEarnings Growth Report & Risk Controlled Daily Plans - newser.com
How RAPT Therapeutics Inc. stock benefits from tech adoptionQuarterly Profit Report & Daily Growth Stock Tips - newser.com
RAPT Therapeutics Inc. recovery potential after sell offMarket Risk Report & Smart Investment Allocation Tips - newser.com
Technical signs of recovery in RAPT Therapeutics Inc.2025 Top Decliners & Verified Swing Trading Watchlist - newser.com
Can RAPT Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com
Wells Fargo Maintains RAPT Therapeutics (RAPT) Overweight Recommendation - Nasdaq
Published on: 2025-11-03 08:21:37 - newser.com
Risk adjusted return profile for RAPT Therapeutics Inc. analyzedWeekly Stock Recap & Free Expert Verified Stock Movement Alerts - newser.com
What to expect from RAPT Therapeutics Inc. in the next 30 daysWeekly Trade Review & Fast Moving Stock Trade Plans - newser.com
Why RAPT Therapeutics Inc. (0RA) stock could break out in 2025Quarterly Earnings Report & Weekly Sector Rotation Insights - newser.com
Published on: 2025-11-03 06:42:26 - newser.com
Why RAPT Therapeutics Inc. (0RA) stock is trending on social mediaJobs Report & Smart Swing Trading Alerts - newser.com
Will RAPT Therapeutics Inc. (0RA0) stock outperform value peersOil Prices & Weekly Stock Performance Updates - newser.com
Analyzing RAPT Therapeutics Inc. with multi timeframe chartsTrade Risk Summary & Weekly High Potential Alerts - newser.com
Does RAPT Therapeutics Inc. (0RA) stock trade below intrinsic value2025 Technical Overview & Weekly High Return Forecasts - newser.com
What macro factors could drive RAPT Therapeutics Inc. (0RA0) stock higherStop Loss & Verified Stock Trade Ideas - newser.com
Tick level data insight on RAPT Therapeutics Inc. volatilityJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com
Is RAPT Therapeutics Inc. stock a buy for dividend growth2025 Risk Factors & Smart Money Movement Alerts - newser.com
Can RAPT Therapeutics Inc. (0RA) stock ride next bull market cycleWeekly Trade Report & AI Enhanced Trade Execution Alerts - newser.com
What makes RAPT Therapeutics Inc. stock attractive to growth funds2025 Market WrapUp & High Accuracy Trade Signal Alerts - newser.com
Why retail investors favor RAPT Therapeutics Inc. stockJuly 2025 Update & Daily Entry Point Alerts - newser.com
What institutional flow reveals about RAPT Therapeutics Inc.Market Risk Analysis & Growth Focused Stock Reports - newser.com
What drives RAPT Therapeutics Inc 0RA0 stock priceMomentum Trading Signals & High Return Trading Strategies - earlytimes.in
Can RAPT Therapeutics Inc. recover in the next quarterJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - newser.com
Leading vs lagging indicators on RAPT Therapeutics Inc. performance2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Is RAPT Therapeutics Inc. (0RA0) stock a buy before earnings resultsWeekly Risk Report & Target Return Focused Picks - newser.com
Is RAPT Therapeutics Inc. (0RA) stock dividend growth reliableJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
RAPT Therapeutics, Inc. (RAPT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
How institutional buying supports RAPT Therapeutics Inc. stockRate Cut & Reliable Intraday Trade Alerts - newser.com
How sentiment analysis helps forecast RAPT Therapeutics Inc.July 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
Is RAPT Therapeutics Inc. stock reversal real or fake2025 Bull vs Bear & Comprehensive Market Scan Reports - newser.com
Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):